Log in to save to my catalogue

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with pri...

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with pri...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e95d32cb646c4ee9abe90f1a0721b0aa

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Neutralization capacity of antibodies against Omicron after a prior SARS-CoV-2 infection in children and adolescents is not well studied. Therefore, we evaluated virus-neutralizing capacity against SARS-CoV-2 Alpha, Beta, Gamma, Delta and Omicron variants by age-stratified analyses (<5, 5–11, 12–21 years) in 177 pediatric patients hospitalized with...

Alternative Titles

Full title

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e95d32cb646c4ee9abe90f1a0721b0aa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e95d32cb646c4ee9abe90f1a0721b0aa

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-30649-1

How to access this item